Note: Ingredients listed on restricted chemical lists
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
General Information
Product name
LINCOCIN INJECTION
1.2.1 Relevant identified uses
Human drug used in the treatment of serious bacterial infections due to susceptible strains of streptococci, pneumococci and staphy lococci
Manufacturer Name
PHARMACIA & UPJOHN
Icons in SDS
Company Information
company name
PHARMACIA & UPJOHN
Section 2
Principle Routes of Exposure
Skin contact, eye contact, ingestion and inhalation EFFECTS OF OVEREXPOSURE: This product is not acutely toxic, but may cause irritation to the eyes, skin and respiratory passages. Repeated exposure may cause nausea, abdominal cramps, diarrhea and colitis which may begin several weeks after exposure has ceased. Some hematopoietic effects have been reported with the use of lincomycin hydrochloride. Hypersensitivity reactions have been reported in people known to be sensitive to penicillin.
Medical Conditions Generally Aggravated by Exposure
Exposure to Lincocin is contraindicated in people with a history of hypersensitivity to lincomycin, clindamycin or related antibiotics, a history of asthma or significant allergies or a history of gastrointestinal disease (especially colitis).
